Paresthesia Treatment Market

Paresthesia Treatment Market by Disease Types (Acute Paresthesia and Chronic Paresthesia), Treatment Types (Anticonvulsants, Immunosuppressants [Intravenous Gamma Globulin, Prednisone, and Others], Antivirals, Topical Creams [Prilocaine, Lidocaine, and Others], and Others), Distribution Channels (Hospitals, Clinics, and Diagnostic Centers), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2021-2028

  • Report ID: HC-3007
  • Author: Growth Market Reports
  • Rating: 4.4
  • Total Reviews: 66
  • No. Of Pages: 222
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global paresthesia treatment market is anticipated to expand at robust CAGR during the forecast period, between 2021 and 2028. Paresthesia refers to a neurological disorder that is distinguished by abnormal sensations where an individual can feel a tingling sensation, numbing, burning, or itching, which is usually painless. This disorder occurs mainly in fingers, toes, hands, and feet. Nerve irritation, neurological disorders, hyperventilation, dehydration, and heavy metal poisoning can cause paresthesia. Long term diseases such as cancer, arthritis, and diabetes can also trigger the risk of this disorder. Paresthesia usually affects the sensory pathway from the peripheral nerve to sensory cortex. The paresthesia treatment market involves various remedies and drugs that help in curing the disorder. The type of treatment that is implemented depends on the cause of paresthesia. If it is caused due to an underlying disease, then getting the treatment can potentially ease the symptoms. However, some types of nerve damages are irreversible and can last a lifetime.

Paresthesia Treatment Market

Market Trends, Drivers, Restraints, and Opportunities:

  • Increasing prevalence of paresthesia among the population is estimated to drive the market growth.
  • Poor lifestyle and dietary choices among people can lead to this disorder, which is one of the key drivers of the paresthesia treatment market.
  • Rising number of cancers, diabetes, and arthritis cases has significantly increased the demand for paresthesia treatment.
  • Lack of effectiveness, stringent regulatory rules, and unavailability of precise treatment can restraint the growth of the market.
  • High cost of treatment can stunt the market growth.
  • Favorable support from the government and medical grants has significantly increased the treatment quality, which is expected to fuel the market in the coming years.

Scope of the report:

The report on the global paresthesia treatment market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Report Title

Paresthesia Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast

Base Year

2020

Historic Data

2018 & 2019

Forecast Period

2021–2028

Segmentation

Types (Acute Paresthesia and Chronic Paresthesia), Treatment Types (Anticonvulsants, Immunosuppressants [Intravenous Gamma Globulin, Prednisone, and Others], Antivirals, Topical Creams [Prilocaine, Lidocaine, and Others], and Others), Distribution Channels (Hospitals, Clinics, and Diagnostic Centers)

Regional Scope

Asia Pacific, North America, Europe, Latin America, and Middle East & Africa

Report Coverage

Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast

Paresthesia Treatment Market Segment Insights:

High prevalence and effectiveness drive the acute paresthesia segment

Based on disease types, the market can be bifurcated into acute paresthesia and chronic paresthesia. The high incidence of acute paresthesia drives the segment as this disorder can be treated based on the underlying cause. When sustained pressure has been applied on a nerve, it inhibits the function and causes temporary discomfort or a tingling sensation. The removal of the pressure results in relief. Chronic paresthesia is found mainly among the geriatric population due to poor blood circulation in the limbs or due to an underlying disease such as arthritis or diabetes. Chronic paresthesia is a much more serious disease and requires immediate treatment as it can subsequently result in permanent damage to the central nervous system. Chronic paresthesia can also be a sign of mercury poisoning.

Paresthesia Treatment Market

The ability to treat neurological disorders drives the anticonvulsants segment

On the basis of treatment types, the paresthesia market can be segmented into anticonvulsants, immunosuppressants, antivirals, topical creams, and others. The immunosuppressants segment can be further divided into intravenous gamma globulin, prednisone, and others while the topical creams segment can be sub-segmented into prilocaine, lidocaine, and others. Anticonvulsants are anti-epileptic drugs that are used to treat seizure disorders.  These are mood stabilizers and are used for the treatment of neuropathy. This segment is expected to grow significantly in the paresthesia treatment market due to its high effectivity in treating acute paresthesia.

Hospitals segment is expected to grow significantly in the forecast period

In terms of distribution channels, the market can be segmented into hospitals, clinics, and diagnostic center . The hospital segment is forecasted to grow at a robust rate due to the wide availability of treatments in hospitals and high accuracy to treat neurological disorders. Moreover, people prefer to get treated in hospitals due to the presence of skilled and experienced doctors and neurologists.

Paresthesia Treatment Market

North America dominates the market

Based on regions, the global paresthesia treatment market can be split into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America constituted a significant share of the market in 2020 due to mergers and acquisitions conducted by key market players. Moreover, increase in R&D spending by key companies and the government in the medical sector are driving the market in North America. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period due to growing R&D expenditure and government initiatives in the field of medicine.

Paresthesia Treatment Market

Segments

Segments covered in the report

By Disease Types

  • Acute Paresthesia
  • Chronic Paresthesia

By Treatment Types

  • Anticonvulsants
  • Immunosuppressants
    • Intravenous Gamma Globulin
    • Prednisone
    • Others
  • Antivirals
  • Topical Creams
    • Prilocaine
    • Lidocaine
    • Others
  • Others

By Distribution Channels

  • Hospitals

  • Clinics

  • Diagnostic Centers

By Regions

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa

Competitive Landscape

Key players in the global paresthesia treatment market include Boston Scientific Corporation; EnteroMedics Inc.; Baxter; Bio-Medical Research Ltd.; GlaxoSmithKline plc; St. Jude Medical LLC; Nevro Corp.; Cyberonics Inc.; Stimwave LLC; and Omron Healthcare Inc. These players engage in mergers & acquisitions; collaborations; agreements; and partnerships to strengthen their geographical presence.

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Paresthesia Treatment Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Paresthesia Treatment Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Paresthesia Treatment Market - Supply Chain
  4.5. Global Paresthesia Treatment Market Forecast
     4.5.1. Paresthesia Treatment Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Paresthesia Treatment Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Paresthesia Treatment Market Absolute $ Opportunity
5. Global Paresthesia Treatment Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Paresthesia Treatment Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Paresthesia Treatment Demand Share Forecast, 2019-2026
6. North America Paresthesia Treatment Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Paresthesia Treatment Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Paresthesia Treatment Demand Share Forecast, 2019-2026
7. Latin America Paresthesia Treatment Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Paresthesia Treatment Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Paresthesia Treatment Demand Share Forecast, 2019-2026
8. Europe Paresthesia Treatment Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Paresthesia Treatment Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Paresthesia Treatment Demand Share Forecast, 2019-2026
9. Asia Pacific Paresthesia Treatment Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Paresthesia Treatment Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Paresthesia Treatment Demand Share Forecast, 2019-2026
10. Middle East & Africa Paresthesia Treatment Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Paresthesia Treatment Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Paresthesia Treatment Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Paresthesia Treatment Market: Market Share Analysis
  11.2. Paresthesia Treatment Distributors and Customers
  11.3. Paresthesia Treatment Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)

Segments covered in the report

By Disease Types

  • Acute Paresthesia
  • Chronic Paresthesia

By Treatment Types

  • Anticonvulsants
  • Immunosuppressants
    • Intravenous Gamma Globulin
    • Prednisone
    • Others
  • Antivirals
  • Topical Creams
    • Prilocaine
    • Lidocaine
    • Others
  • Others

By Distribution Channels

  • Hospitals

  • Clinics

  • Diagnostic Centers

By Regions

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa

Key players in the global paresthesia treatment market include Boston Scientific Corporation; EnteroMedics Inc.; Baxter; Bio-Medical Research Ltd.; GlaxoSmithKline plc; St. Jude Medical LLC; Nevro Corp.; Cyberonics Inc.; Stimwave LLC; and Omron Healthcare Inc. These players engage in mergers & acquisitions; collaborations; agreements; and partnerships to strengthen their geographical presence.

Buy Report